Merck KGaA (OTCMKTS:MKGAF – Get Free Report) shares were down 6.8% on Thursday . The company traded as low as $134.9420 and last traded at $134.9430. Approximately 817 shares were traded during trading, a decline of 7% from the average daily volume of 878 shares. The stock had previously closed at $144.8350.
Merck KGaA Stock Performance
The firm’s 50-day simple moving average is $135.21 and its 200-day simple moving average is $132.01. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The company has a market capitalization of $18.87 billion, a PE ratio of 22.29 and a beta of 0.96.
About Merck KGaA
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
See Also
- Five stocks we like better than Merck KGaA
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Ulta’s Stock May Be Set for a Glow-Up—20% Upside Ahead?
- How to buy stock: A step-by-step guide for beginners
- Gates Foundation Sells MSFT Stock—Should Investors Be Worried?
- How to Invest in Insurance Companies: A Guide
- MarketBeat Week in Review – 12/1 – 12/5
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
